Feeding, simvastatin, and linezolid.
Feeding, simvastatin, and linezolid.
复制标题
喂养,辛伐他汀和利奈唑胺。
DOI:
10.1164/rccm.201203-0549rr
复制
发表时间:
2012
影响因子:
24.7
通讯作者:
Braun,AndrewT
中科院分区:
文献类型:
--
作者:
Kamdar,BirenB;Akulian,JasonA;Braun,AndrewT
Nutritional support is important but particularly challenging for patients receiving mechanical ventilation. Current guidelines for this population recommend early initiation of enteral feeding, supported by data associating enteral feeding with improved mortality and infection outcomes (2). Despite these recommendations, the optimal dose of enteral nutrition in intensive care unit patients remains unknown. Although some studies suggest that full enteric nutrition improves outcomes, others have demonstrated that trophic (minimal) feedings are sufficient and produce fewer gastrointestinal complications (2). To resolve these conflicting data, Rice and colleagues present the results of an ARDS Clinical Trials Network randomized controlled trial comparing full versus trophic feeding in critically ill patients with acute lung injury (ALI)(1). Within 48 hours of ALI onset and 72 hours of initiation of mechanical ventilation, patients at 44 hospitals were randomized to receive 6 days of either a full-feeding protocol, starting at 25 ml/hour and up-titrated as tolerated toward a caloric goal, or a 10-ml/hour trophicfeeding protocol. After 6 days, patients still receiving mechanical ventilation were given the full-feeding protocol. During the study period, the 492 patients in the full-feeding group received approximately 1,300 kcal each day (80% of goal), whereas the 508 patients in the trophic-feeding group received approximately 400 kcal (25% of goal). Comparing the full-and trophic-feeding groups, there were no significant differences in ventilator-free days (15.0 vs. 14.9; P= 0.89), 60-day mortality (22.2 vs. 23.2%; P= 0.77), infection rates, organ failure–free days, or intensive care unit–free days. The trophic-feeding group had significantly lower gastric residual volumes and rates of regurgitation, emesis, and constipation, but actual rates of these complications were low in both groups.The strengths of this study include its randomized, intentionto-treat design, large size, and use of standardized dosing protocols. Limitations include its open-label, nonequivalence design and the exclusion of critically ill patients without ALI. Overall, this well-designed randomized controlled trial demonstrated no difference in ventilator-free days or mortality with initial full versus trophic feeding, and supports the relative safety of both strategies in ALI. It remains unknown whether other clinically important outcomes related to the timing or duration of feeding exist to favor one strategy over the other.